Apelin enhances directed cardiac differentiation of mouse and human embryonic stem cells

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Wang, I Ning E ^a   Wang, Xiang ^a   Ge, Xiaohu ^a   Anderson, Joshua ^a   Ho, Michael ^a   Ashley, Euan ^a   Liu, Jianwei ^a   Butte, Manish J ^a   Yazawa, Masayuki ^a   Dolmetsch, Ricardo E ^a   Quertermous, Thomas ^a   Yang, Phillip C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; APELIN; APELIN RECEPTOR; BONE MORPHOGENETIC PROTEIN 4; CELL SURFACE MARKER; DICKKOPF 1 PROTEIN; DILTIAZEM; FIBROBLAST GROWTH FACTOR 2; G PROTEIN COUPLED RECEPTOR; ISOPRENALINE; LIGAND; PEPTIDE; VASCULOTROPIN; ACTIN; ACTIVIN; APELIN 13 PEPTIDE; APELIN-13 PEPTIDE; CONNEXIN 43; SIGNAL PEPTIDE; TROPONIN T;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FATE; CELL LINE; CELL MIGRATION; CONCENTRATION RESPONSE; EMBRYOID BODY; EMBRYONIC STEM CELL; GENE CONTROL; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MESODERM; MOUSE; NONHUMAN; PHENOTYPE; UPREGULATION; ANIMAL; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; HEART CONTRACTION; METABOLISM;

ACTINS; ACTIVINS; ANIMALS; BONE MORPHOGENETIC PROTEIN 4; CELL DIFFERENTIATION; CELL LINE; CONNEXIN 43; EMBRYOID BODIES; EMBRYONIC STEM CELLS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; TROPONIN T;

EID: 84861726051     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038328     Document Type: Article

References (42)

1. Weir RA, McMurray JJ, Velazquez EJ, (2006) Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: prevalence, clinical characteristics, and prognostic importance. Am J Cardiol, 97, 13F-25F.
2. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, et al. (2012) Heart disease and stroke statistics-2012 update: a report from the american heart association. Circulation, 125, e2-e220.
3. Thygesen K, Alpert JS, White HD, (2007) Universal definition of myocardial infarction. Eur Heart J, 28, 2525-2538.
4. Hunter JJ, Chien KR, (1999) Signaling pathways for cardiac hypertrophy and failure. N Engl J Med, 341, 1276-1283.
5. Behfar A, Perez-Terzic C, Faustino RS, Arrell DK, Hodgson DM, et al. (2007) Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J Exp Med, 204, 405-420.
6. Beaglehole R, Bonita R, Horton R, Adams O, McKee M, (2004) Public health in the new era: improving health through collective action. Lancet, 363, 2084-2086.
7. Urbanek K, Torella D, Sheikh F, De AA, Nurzynska D, et al. (2005) Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci USA, 102, 8692-8697.
8. Urbanek K, Rota M, Cascapera S, Bearzi C, Nascimbene A, et al. (2005) Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res, 97, 663-673.
9. Amir G, Ma X, Reddy VM, Hanley FL, Reinhartz O, et al. (2008) Dynamics of human myocardial progenitor cell populations in the neonatal period. Ann Thorac Surg, 86, 1311-1319.
10. Zhang F, Pasumarthi KB, (2008) Embryonic stem cell transplantation: promise and progress in the treatment of heart disease. Bio Drugs, 22, 361-374.
11. Zhu WZ, Hauch KD, Xu C, Laflamme MA, (2009) Human embryonic stem cells and cardiac repair. Transplant Rev (Orlando.), 23, 53-68.
12. Hendry SL, van der Bogt KE, Sheikh AY, Arai T, Dylla SJ, et al. (2008) Multimodal evaluation of in vivo magnetic resonance imaging of myocardial restoration by mouse embryonic stem cells. J Thorac Cardiovasc Surg, 136, 1028-1037.
13. Burridge PW, Thompson S, Millrod MA, Weinberg S, Yuan X, et al. (2011) A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One, 6 (4), e18293.
14. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, et al. (2001) Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest, 108, 407-414.
15. Segev H, Kenyagin-Karsenti D, Fishman B, Gerecht-Nir S, Ziskind A, et al. (2005) Molecular analysis of cardiomyocytes derived from human embryonic stem cells. Dev Growth Differ, 47, 295-306.
16. Yang L, Soonpaa MH, Adler ED, Roepke TK, Kattman SJ, et al. (2008) Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature, 453, 524-528.
17. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, et al. (1998) Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun, 251, 471-476.
18. O'Dowd BF, Heiber M, Chan A, Heng HH, Tsui LC, et al. (1993) A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene, 136, 355-360.
19. Scott IC, Masri B, D'Amico LA, Jin SW, Jungblut B, et al. (2007) The g protein-coupled receptor agtrl1b regulates early development of myocardial progenitors. Dev Cell, 12, 403-413.
20. Zeng XX, Wilm TP, Sepich DS, Solnica-Krezel L, (2007) Apelin and its receptor control heart field formation during zebrafish gastrulation. Dev Cell, 12, 391-402.
21. Tempel D, de Boer M, van Deel E, Haasdijk RA, Duncker DJGM, et al. (2010) Apelin/Agtrl1 signaling, a new regulatory pathway in progenitor cell trafficking after myocardial infarction in mice. Scientific Sessions 2010, American Heart Association.
22. Ashley EA, Powers J, Chen M, Kundu R, Finsterbach T, et al. (2005) The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc Res, 65, 73-82.
23. Inui M, Fukui A, Ito Y, Asashima M, (2006) Xapelin and Xmsr are required for cardiovascular development in Xenopus laevis. Dev Biol, 298, 188-200.
24. Suzuki Y, Zhang S, Kundu P, Yeung AC, Robbins RC et al, (2007) In vitro comparison of the biological effects of three transfection methods for magnetically labeling mouse embryonic stem cells with ferumoxides. Magn Reson Med, 57, 1173-1179.
25. Wang X, Yang P, (2008) In vitro differentiation of mouse embryonic stem (mES) cells using the hanging drop method. J Vis Exp, (17). pii doi:10.3791/825.
26. Yazawa M, Hsueh B, Jia X, Pasca AM, Bernstein JA, et al. (2011) Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature, 471, 230-234.
27. Kelly RG, Brown NA, Buckingham ME, (2001) The arterial pole of the mouse heart forms from Fgf10-expressing cells in pharyngeal mesoderm. Dev Cell, 1, 435-440.
28. Cai CL, Liang X, Shi Y, Chu PH, Pfaff SL, et al. (2003) Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell, 5, 877-889.
29. Mjaatvedt CH, Nakaoka T, Moreno-Rodriguez R, Norris RA, Kern MJ, et al. (2001) The outflow tract of the heart is recruited from a novel heart-forming field. Dev Biol, 238, 97-109.
30. Waldo KL, Kumiski DH, Wallis KT, Stadt HA, Hutson MR, et al. (2001) Conotruncal myocardium arises from a secondary heart field. Development, 128, 3179-3188.
31. Zaffran S, Kelly RG, Meilhac SM, Buckingham ME, Brown NA, (2004) Right ventricular myocardium derives from the anterior heart field. Circ Res, 95, 261-268.
32. Charron F, Nemer M, (1999) GATA transcription factors and cardiac development. Semin Cell Dev Biol, 10, 85-91.
33. Harvey RP, (1996) NK-2 homeobox genes and heart development. Dev Biol, 178, 203-216.
34. Biben C, Harvey RP, (1997) Homeodomain factor Nkx2-5 controls left/right asymmetric expression of bHLH gene eHand during murine heart development. Genes Dev, 11, 1357-1369.
35. D'Aniello C, Lonardo E, Iaconis S, Guardiola O, Liguoro AM, et al. (2009) G protein-coupled receptor APJ and its ligand apelin act downstream of Cripto to specify embryonic stem cells toward the cardiac lineage through extracellular signal-regulated kinase/p70S6 kinase signaling pathway. Circ Res, 105, 231-238.
36. Charo DN, Ho M, Fajardo G, Kawana M, Kundu RK, et al. (2009) Endogenous regulation of cardiovascular function by apelin-APJ. Am J Physiol Heart Circ Physiol, 297, H1904-H1913.
37. Szokodi I, Tavi P, Foldes G, Voutilainen-Myllyla S, Ilves M, et al. (2002) Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res, 91, 434-440.
38. Barnes G, Japp AG, Newby DE, (2010) Translational promise of the apelin-APJ system. Heart, 96, 1011-1016.
39. Dai T, Ramirez-Correa G, Gao WD, (2006) Apelin increases contractility in failing cardiac muscle. Eur J Pharmacol, 553, 222-228.
40. Maguire JJ, Kleinz MJ, Pitkin SL, Davenport AP, (2009) [Pyr1]apelin-13 identified as the predominant apelin isoform in the human heart: vasoactive mechanisms and inotropic action in disease. Hypertension, 54, 598-604.
41. Wang C, Du JF, Wu F, Wang HC, (2008) Apelin decreases the SR Ca2+ content but enhances the amplitude of [Ca2+]i transient and contractions during twitches in isolated rat cardiac myocytes. Am J Physiol Heart Circ Physiol, 294, H2540-H2546.
42. Karmazyn M, Gan XT, Humphreys RA, Yoshida H, Kusumoto K, (1999) The myocardial Na(+)-H(+) exchange: structure, regulation, and its role in heart disease. Circ Res, 85, 777-786.